Novusvita
Natural health product licensed in Canada
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 80004017
- Status
- Inactive licence
- Licence date
- 11 September 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide pantothénique | 3 mg | Not calculated |
| Thiamine | 2 mg | Not calculated |
| Calcium | 300 mg | Not calculated |
| Vitamine E | 25 mg | Not calculated |
| Folate | 0.5 mg | Not calculated |
| Vitamine B6 | 5 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Poly(éthylène glycol), Quinoline Yellow WS, Béhénate de glycéryle, Croscarmellose de sodium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes (enceintes et/ou allaitantes) | minimum: 19 years ; maximum: 50 years | 1 Comprimé | 2 Tous les jours |
| Adultes (enceintes et/ou allaitantes) | minimum: 14 years ; maximum: 18 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Contribute to maintain a good health for the mother and baby.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Contribute to maintain a good health for the mother and baby. Risk Information/Renseignements sur les risques: Consult a health care practitioner prior to use if you have impaired liver function. Discontinue use if you experience a prolonged flushing, burning, tingling or itching sensation on the face, arms or chest. Do not use if you have a coppers storage or metabolism disorder such as Wilson's disease. Consult a health care practitioner prior to use if you are taking Tetracyclines. Avoid using two (2) hours prior to or until four (4) hours after taking other medications. Keep out of reach of children. There is enough drug in the package to seriously harm a child.
Source
Official Health Canada record, licence 80004017
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.